Security key
68235C107
Oncocyte Corporation - Common Shares, No Par Value (OCX)
CUSIP: 68235C107
Q4 2021 13F Holders as of 31 Dec 2021
- Security type / class
- Equity / Common Shares, No Par Value
- Total 13F shares
- 55,309,802
- Total 13F value
- $119,904,059
- Share change
- -1,227,886
- Put/Call ratio
- 15%
- SEC-reported price per share
- $2.17
- Number of holders
- 82
- Value change
- -$4,932,956
- Number of buys
- 33
- Number of sells
- 45
- Shares outstanding
- 28,495,649
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2021
Institutions
82
Top holders
10
OCX full security history
Ownership snapshot
Full 13F holder table
Insight Molecular Diagnostics Inc. SEC filings
Insight Molecular Diagnostics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BROADWOOD CAPITAL INC
Disclosed value leader
BROADWOOD CAPITAL INC
Comparable rows
0/15
Latest evidence
30 Sep 2021
13F
Highest disclosed value: $61,766,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BROADWOOD CAPITAL INC has the largest disclosed position value at $61.77M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BROADWOOD CAPITAL INC's linked filing trail.
Disclosed position value
Top 5
BROADWOOD CAPITAL INC
$61.77M
PURA VIDA INVESTMENTS, LLC
$43.52M
BlackRock Finance, Inc.
$15.55M
VANGUARD GROUP INC
$13.8M
ORBIMED ADVISORS LLC
$10.17M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
Company
|
—
denominator unverified
|
$61,766,000
17,349,945 shares
|
— | 30 Sep 2021 |
| PURA VIDA INVESTMENTS, LLC |
13F
Company
|
—
denominator unverified
|
$43,517,000
12,223,953 shares
|
— | 30 Sep 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$15,552,000
4,368,726 shares
|
— | 30 Sep 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$13,799,000
3,875,977 shares
|
— | 30 Sep 2021 |
| ORBIMED ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$10,167,000
2,856,000 shares
|
— | 30 Sep 2021 |
| Defender Capital, LLC. |
13F
Company
|
—
denominator unverified
|
$6,935,000
1,960,820 shares
|
— | 30 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
82
Shares
55,309,802
Rows available
82
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
91
Q4 2021 holders
82
Holder diff
-9
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 value | Q4 2021 value | Value change | Value Chg % |
|---|